386 related articles for article (PubMed ID: 19477487)
41. Endothelial haemostatic markers in members of families with familial combined hyperlipidemia.
Karásek D; Vaverková H; Halenka M; Slavík L; Novotný D
Thromb Res; 2009; 123(3):466-75. PubMed ID: 18417194
[TBL] [Abstract][Full Text] [Related]
42. Endothelial function and novel adhesion molecule CD44 in kidney allograft recipients.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Transplant Proc; 2008 Dec; 40(10):3470-3. PubMed ID: 19100415
[TBL] [Abstract][Full Text] [Related]
43. von Willebrand factor binding to collagen in patients with end-stage renal disease.
Niesvizky R; Calandri C; Patel ND; Zhou SL; Potter BJ; Rand JH
J Lab Clin Med; 1994 Jan; 123(1):137-42. PubMed ID: 8288954
[TBL] [Abstract][Full Text] [Related]
44. Endothelial dysfunction and oxidative stress in type 1 and type 2 diabetic patients without clinical macrovascular complications.
De Mattia G; Bravi MC; Laurenti O; Moretti A; Cipriani R; Gatti A; Mandosi E; Morano S
Diabetes Res Clin Pract; 2008 Feb; 79(2):337-42. PubMed ID: 17949845
[TBL] [Abstract][Full Text] [Related]
45. Oral vitamin C supplementation in hemodialysis patients and its effect on the plasma level of oxidized ascorbic acid and Cu/Zn superoxide dismutase, an oxidative stress marker.
Washio K; Inagaki M; Tsuji M; Morio Y; Akiyama S; Gotoh H; Gotoh T; Gotoh Y; Oguchi K
Nephron Clin Pract; 2008; 109(2):c49-54. PubMed ID: 18544955
[TBL] [Abstract][Full Text] [Related]
46. Endothelial marker proteins in hyperhomocysteinemia.
de Jong SC; Stehouwer CD; van den Berg M; Vischer UM; Rauwerda JA; Emeis JJ
Thromb Haemost; 1997 Nov; 78(5):1332-7. PubMed ID: 9408014
[TBL] [Abstract][Full Text] [Related]
47. Tissue factor and urokinase-type plasminogen activator system are related to the presence of cardiovascular disease in hemodialysis patients.
Pawlak K; Pawlak D; Mysliwiec M
Thromb Res; 2007; 120(6):871-6. PubMed ID: 17331567
[TBL] [Abstract][Full Text] [Related]
48. Relationship between endothelial dysfunction, oxidant stress and aspirin resistance in patients with stable coronary heart disease.
Cheng G; Shan J; Xu G; Liu P; Zhou Y; Zhu Y; Lu X
J Clin Pharm Ther; 2007 Jun; 32(3):287-92. PubMed ID: 17489881
[TBL] [Abstract][Full Text] [Related]
49. Oxidized low-density lipoprotein (oxLDL) plasma levels and oxLDL to LDL ratio - are they real oxidative stress markers in dialyzed patients?
Pawlak K; Mysliwiec M; Pawlak D
Life Sci; 2013 Mar; 92(4-5):253-8. PubMed ID: 23295961
[TBL] [Abstract][Full Text] [Related]
50. Oxidative stress in children with acute glomerulonephritis.
Bülbül M; Oner A; Demircin G; Erdoğan O
Ren Fail; 2008; 30(2):209-14. PubMed ID: 18300123
[TBL] [Abstract][Full Text] [Related]
51. Erythropoietin therapy decreased tissue factor, its pathway inhibitor, and oxidative stress in peritoneal dialysis patients with diabetes.
Pawlak K; Pawlak D; Mysliwiec M
Nephron Clin Pract; 2007; 107(1):c20-5. PubMed ID: 17671395
[TBL] [Abstract][Full Text] [Related]
52. Association between tissue factor, its pathway inhibitor and oxidative stress in peritoneal dialysis patients.
Pawlak K; Pawlak D; Mysliwiec M
Blood Coagul Fibrinolysis; 2007 Jul; 18(5):467-71. PubMed ID: 17581322
[TBL] [Abstract][Full Text] [Related]
53. Free and total plasma malondialdehyde in chronic renal insufficiency and in dialysis patients.
De Vecchi AF; Bamonti F; Novembrino C; Ippolito S; Guerra L; Lonati S; Salini S; Aman CS; Scurati-Manzoni E; Cighetti G
Nephrol Dial Transplant; 2009 Aug; 24(8):2524-9. PubMed ID: 19264746
[TBL] [Abstract][Full Text] [Related]
54. Kynurenine and its metabolites in the rat with experimental renal insufficiency.
Pawlak D; Tankiewicz A; Buczko W
J Physiol Pharmacol; 2001 Dec; 52(4 Pt 2):755-66. PubMed ID: 11785771
[TBL] [Abstract][Full Text] [Related]
55. Unfractionated heparin but not enoxaparin causes delayed plasma PAI-1 depletion in hemodialysis patients: a prospective study.
Naumnik B; Pawlak K; Mys'liwiec M
Clin Appl Thromb Hemost; 2009 Feb; 15(1):84-91. PubMed ID: 17895513
[TBL] [Abstract][Full Text] [Related]
56. The effects of exercise stress testing on soluble E-selectin, von Willebrand factor, and circulating endothelial cells as indices of endothelial damage/dysfunction.
Boos CJ; Balakrishnan B; Lip GY
Ann Med; 2008; 40(1):66-73. PubMed ID: 17934907
[TBL] [Abstract][Full Text] [Related]
57. Chronic viral hepatitis C, oxidative stress and the coagulation/fibrinolysis system in haemodialysis patients.
Pawlak K; Zolbach K; Borawski J; Mysliwiec M; Kovalchuk O; Chyczewski L; Pawlak D
Thromb Res; 2008; 123(1):166-70. PubMed ID: 18452978
[TBL] [Abstract][Full Text] [Related]
58. Relations between von Willebrand factor, markers of oxidative stress and microalbuminuria in patients with type 2 diabetes mellitus.
Ibrahim HA; El-Meligi AA; Abdel-Hamid M; Elhendy A
Med Sci Monit; 2004 Mar; 10(3):CR85-9. PubMed ID: 14976459
[TBL] [Abstract][Full Text] [Related]
59. Markers of endothelial function in pediatric stem cell transplantation for acute leukemia.
Luzzatto G; Cella G; Messina C; Randi ML; Sbarai A; Zanesco L
Med Pediatr Oncol; 2003 Jan; 40(1):9-12. PubMed ID: 12426679
[TBL] [Abstract][Full Text] [Related]
60. Plasma levels of free and total TFPI, relationship with cardiovascular risk factors and endothelial cell markers.
Morange PE; Renucci JF; Charles MA; Aillaud MF; Giraud F; Grimaux M; Juhan-Vague I
Thromb Haemost; 2001 Jun; 85(6):999-1003. PubMed ID: 11434709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
